Exosomes obtained from AKT-modified human umbilical cord mesenchymal stem cells are highly effective at promoting angiogenesis in myocardial infarction therapy, and platelet-derived growth factor D (PDGFD) in the exosomes also plays a crucial role in angiogenesis [14]. The gene discussed is AKT1; the disease is myocardial infarction.